Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus Hotspot.
Headache
; 60(6): 1183-1186, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-155342
ABSTRACT
The COVID-19 pandemic has undoubtedly changed our practice of medicine. With our collective resources and attention focused on caring for those afflicted with the disease, other medical conditions have temporarily but understandably faced constraint. For migraine patients who often require in-person visits for infusions and procedures, this has become particularly challenging. Here, we share our experience in navigating this exigency amidst a local surge of COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Botulinum Toxins, Type A
/
Pandemics
/
Time-to-Treatment
/
Betacoronavirus
/
Migraine Disorders
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
/
Qualitative research
Topics:
Variants
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
English
Journal:
Headache
Year:
2020
Document Type:
Article
Affiliation country:
Head.13830
Similar
MEDLINE
...
LILACS
LIS